Four Dlx homeobox genes, Dlx1, Dlx2, Dlx5, and Dlx6 are expressed in the same primordia of the mouse forebrain with temporally overlapping patterns. The four genes are organized as two tail-to-tail pairs, Dlx1/Dlx2 and Dlx5/Dlx6, a genomic arrangement conserved in distantly related vertebrates like zebrafish. The Dlx5/Dlx6 intergenic region contains two sequences of a few hundred base pairs, remarkably well conserved between mouse and zebrafish. Reporter transgenes containing these two sequences are expressed in the forebrain of transgenic mice and zebrafish with patterns highly similar to endogenous Dlx5 and Dlx6 expression. The activity of the transgene is drastically reduced in mouse mutants lacking both Dlx1 and Dlx2, consistent with the decrease in endogenous Dlx5 and Dlx6 expression. These results suggest that crossregulation by Dlx proteins, mediated by the intergenic sequences, is essential for Dlx5 and Dlx6 expression in the forebrain. This hypothesis is supported by cotransfection and DNA-protein binding experiments. We propose that the Dlx genes are part of a highly conserved developmental pathway that regulates forebrain development.
The Dl x family of vertebrate homeobox genes comprises six members in mammals and at least eight in the zebrafish (Stock et al., 1996) . Four Dl x genes, Dl x1, Dl x2, Dl x5, and Dl x6 are involved in development of the ventral telencephalon and diencephalon of mammals (Porteus et al., 1991; Price et al., 1991; Robinson et al., 1991; Simeone et al., 1994; Liu et al., 1997) , and the expression patterns of these four genes, although distinct overall, overlap significantly. Mice lacking either Dl x1 or Dl x2 function show normal or nearly normal development of the subcortical telencephalon. However, mice lacking both Dl x1 and Dlx2 functions show stronger abnormalities in the development of the striatal subventricular zone, in the differentiation of striatal matrix neurons, and in the migration of neocortical interneurons from the subcortical telencephalon (Anderson et al., 1997a,b) .
Interestingly, expression of Dlx5 and Dlx6 is reduced in the subventricular zone, but not in the mantle of the double mutants, suggesting that Dlx1 and/or Dlx2 might be required for the maintenance of Dlx5/Dlx6 expression in subventricular zone cells. Mice lacking Dlx5 function show defects in the branchial arches and in epithelium derived from the olfactory and otic placodes, but not in the forebrain (Acampora et al., 1999; Depew et al., 1999) . Mutants lacking both Dlx5 and Dlx6 functions have yet to be reported.
The zebrafish dlx1, dlx2, dlx4, and dlx6 genes are the orthologs of the mammalian Dlx1, Dlx2, Dlx5, and Dlx6 genes, respectively (Akimenko et al., 1994; Stock et al., 1996) . These four zebrafish genes are also expressed in the ventral forebrain with patterns very similar to those of their murine counterparts (Ellies et al., 1997) . The similarities between the mouse and zebrafish Dlx orthologs also extend to their genomic organization. In both species, the four genes are organized as two pairs of convergently transcribed genes, the Dlx1/Dlx2 pair and the Dlx5/Dlx6 pair (dlx4/dlx6 in zebrafish; Simeone et al., 1994; McGuinness et al., 1996; Ellies et al., 1997) . The relatively short distances (2.5-10 kb) that separate the two genes in such pairs and the similarities in the expression patterns of the two genes that constitute a pair (Ellies et al., 1997) suggest the presence, in the intergenic region, of shared cis-acting regulatory elements.
In the present study, we have examined the molecular basis for the overlapping expression of Dlx genes in the ventral forebrain of vertebrates. We have identified highly conserved sequences in the intergenic region between Dlx5/Dlx6 (dlx4/dlx6). These sequences extend over a few hundred base pairs and are the potential site of action of a vast number of regulatory factors. We present evidence that the Dlx proteins themselves constitute some of these factors. Taken together, these results suggest that cross-regulatory mechanisms between Dl x genes and enhancersharing are important aspects of Dl x regulation in the forebrain.
MATERIALS AND METHODS
Identification of conserved sequences in the zebrafish dlx4/dlx6 and mouse Dlx5/ Dlx6 intergenic reg ions. Restriction fragments of a genomic clone containing the zebrafish dl x4/dl x6 locus (Ellies et al., 1997) were radiolabeled and hybridized to a Southern blot of various restriction digests of a mouse genomic clone containing the orthologous Dl x5/Dl x6 locus (Liu et al., 1997) . Of the zebrafish restriction fragments from the dl x4/dl x6 locus, only a 1.4 kb XhoI-EcoRI fragment from the intergenic region hybridized to the mouse genomic fragments (Fig. 1 ). This zebrafish fragment and the hybridizing mouse fragments were sequenced using the dideoxy procedure. Sequence accession numbers are: for the zebrafish sequence (AF201695) and for the mouse sequences (AF201696 and AF201697). A search of the GenBank database with the zebrafish 1.4 kb XhoI-EcoRI fragment enabled us to identif y a human BAC clone containing the DL X5/DL X6 locus (sequence accession number AC004774).
Nucleotide sequence comparisons were done using the GCG software package and the CLUSTAL W version 1.7 multiple sequence alignment program (Thompson, 1984) .
Transgenic animals. DNA fragments from either the zebrafish dl x4/dl x6 locus or from the mouse Dl x5/Dl x6 locus were subcloned into the p1229 or p1230 vectors (Yee and Rigby, 1993) . For the production of transgenic mice, the transgene was excised from the plasmid construct and injected at a concentration of 5 ng /l in eggs from FV B/n crosses using standard procedures (Hogan et al., 1986) . Transgenes were analyzed in either founder embryos or from established transgenic lines. Presence of the transgene was determined by PCR on DNA prepared from extraembryonic tissues with the following oligonucleotide primers 5Ј-AGGGCAGAGCCATC TATTGC -3Ј and 5Ј-CGC TCATCCGCCA-CATATCC-3Ј derived, respectively, from the ␤-globin promoter and lacZ sequences of the p1229/p1230 vectors. Amplification of a fetal hemoglobin gene sequence was used as a positive control (primers are x1: 5Ј-GATCATGACCGCCGTAGG-3Ј and x2: 5Ј-CATGAACTTGTCCCAG-GCTT-3Ј.
For the production of transgenic zebrafish, a 1.4 kb XhoI-EcoRI fragment of the zebrafish dl x4/dl x6 intergenic region was inserted upstream of the ␤-globin promoter fragment taken from the p1230 vector and of the coding sequence of a variant of the green fluorescent protein (GFP) GM2 that emits ϳ30-fold higher fluorescence than does the wild-type GFP, under standard FI TC conditions (Cormack et al., 1996) . Linearized plasmid DNA was injected into single-cell wild-type zebrafish embryos that were examined for GFP expression at various time points thereafter as previously described (L ong et al., 1997) .
Morpholog ical anal ysis of transgenic animals. Founder transgenic embryos or embryos from the cross of a transgenic male with normal FV B or CD1 females were harvested at various embryonic stages. Transgene expression was also analyzed in newborn pups, young mice, and adults from established lines. Embryos were fixed in 1% formaldehyde, 0.2% glutaraldehyde, 0.02% N P-40 in PBS for 30 min at 4°C, washed in PBS for 20 min at room temperature, and stained for ␤-galactosidase activity overnight at 28°C in a solution of 1 mg /ml X-gal, 5 mM K 3 Fe(C N) 6 , 5 mM K 4 Fe(C N) 6 , 2 mM MgC l 2 , and 0.02% N P-40 in PBS.
Breeding with mouse null mutants. Mice heterozygous for the zfdl x4/ 6lacZ-transgene were mated to partners heterozygous for a deletion of the Dl x1 and Dl x2 genes (strain C57 Bl /6; described in Qiu et al., 1997) . Offspring were genotyped by PCR, with the primers described above to detect the transgene, and with primers corresponding to the neomycin resistance gene that marks the Dl x1/2 deletion. Animals that were heterozygous for both modifications (genotype Dl x1/2ϩ/Ϫ; zfdl x4/ 6lacZϩ/Ϫ) were mated to generate mice that were homozygous for the deletion of the Dl x1/2 locus (Dl x1/2Ϫ/Ϫ; zfdl x4/6lacZ). Mutant embryos were identified by either diagnosing a cleft palate (E15 and later) or by Figure 1 . Genomic organization of the zebrafish dl x4 and dl x6 genes (top) and of the orthologous murine Dl x5 and Dl x6 (bottom), indicating the location of conserved sequences with putative regulatory f unction. The third exons of zebrafish dl x4 and dl x6 and of mouse Dl x5 and Dl x6 are represented by boxes. Direction of transcription is indicated by arrows. B, BamHI; E, EcoRI; X, XhoI; S, SacI; Sa, SalI. The constructs for the production of transgenic animals and for transfection experiments are schematized. The position and orientation of the intergenic fragments relative to the reporter genes (lacZ, CAT, or GFP) is shown. ␤, Minimal ␤-globin promoter; tk, thymidine k inase promoter. Numbers of primary transgenic embryos or embryos from transgenic lines that show lacZ expression in various sites of Dl x expression are indicated to the right of each construct. the absence of a PCR product, with primers that recognize the deleted portion of Dl x1.
Constructs for transient cotransfection e xperiments. An effector plasmid that expresses the zebrafish dl x2 gene under control of the SV40 early promoter was constructed by inserting an 845 bp PCR-amplified EcoRI fragment of the zebrafish dl x2 cDNA (Akimenko et al., 1994) encompassing the f ull coding sequence into the EcoRI site of the pTL2 expression vector (M. Petkovich, unpublished observations). Reporter plasmids were constructed by inserting fragments of the zebrafish dl x4/ dl x6 intergenic region into the pBLCAT2 vector (L uckow and Schütz, 1987) , which contains the thymidine k inase (tk) minimal promoter driving expression of the chloramphenicol acet yltransferase (CAT) gene. The 1.4 kb XhoI-EcoRI fragment from the zebrafish dl x4/dl x6 intergenic region (I4/6; Fig. 1 ) was subcloned into pBLCAT2 directly upstream of the tk promoter. The zI46i and zI46ii fragments and deletions of zI46i were prepared by PCR from a pBluescript clone containing the 1.4 kb XhoIEcoRI I4/6 fragment. The zI46ii fragment was inserted in pBLCAT2 directly upstream of the tk promoter, and the zI46i fragment was inserted immediately downstream of the CAT gene (i.e., 4.5 kb upstream of the tk promoter in the circular plasmid).
The following oligonucleotides: 1060, 5Ј-GC TC TAGAATTAGTT-TAACGTCGAA-3Ј; 473, 5Ј-GGGGTACCGC TGGGGCATCCAC -GAT-3Ј; 187, 5Ј-GGGGTACCATTCTCATAAATGCAG-3Ј; 204, 5Ј-GGGGTACC TGCATTTATGAGAATG-3Ј; 305, 5Ј-GGGGTACC -ATC TTTATTTGGATT-3Ј; and 316, 5Ј-GGGGTACCAAATAAA-GATGCC TTT-3Ј were used to prepare deletion fragments from zI46i using PCR. The numeric name of the oligonucleotide refers to the position, in the conserved intergenic sequence (Fig. 2 A) , that borders the amplified fragment. Restriction sites (XbaI or KpnI) were introduced at the 5Ј end of each oligonucleotide. PCR products: f ull-length zI46i (positions 1-473 in GenBank sequence AF201695), zI46i 1-204 (positions 1-204 in the same sequence), zI46i 187-316, and zI46i 305-473, were PCR-amplified and subcloned into pBLCAT2.
Mutagenesis. T wo putative Dlx-binding sites (Feledy et al., 1999 ) in zI46i, found at sequence positions 207-214 and 263-270; were mutagenized using the Sculptor in vitro mutagenesis system (Amersham, Arlington Heights, IL). The AATTA and AATT sequences in those sites were changed to TC TAG and C TAG, respectively, to generate the ⌬210 and ⌬266 mutations. The double mutant ⌬210/⌬266 was obtained by mutagenesis of the zI46i fragment already containing the ⌬266 mutation with the same oligonucleotide used to produce the ⌬210 mutation. The 187-316 fragments of zI46i containing either the ⌬210 mutation, the ⌬266 mutation, or both of them, were inserted into the pBLCAT2 vector for transfection experiments or in the p1230 vector to produce transgenic animals.
Transient cotransfection e xperiments. Transient cotransfection experiments were performed in the P19 murine embryonic carcinoma (EC) cell line essentially as described previously (Z erucha et al., 1997) . C ells were seeded 24 hr before transfection at a density of 10 7 cells per 100 mm dish. Transfections were performed by the calcium phosphate precipitation procedure (Sambrook et al., 1989) . A total of 10 g of DNA per dish was used in each transfection. This included 2 g pRSV-␤gal as an internal control for transfection efficiency, 2 g of reporter plasmid, 2 g of effector plasmid, and sheared calf thymus DNA (Boehringer Mannheim, Indianapolis, I N) to the total of 10 g. Precipitates were left on the cells for 16 hr, and the cells were harvested 64 hr after transfection. C ells were collected in PBS, pelleted by centrif ugation, and resuspended in freeze/ thaw buffer (250 mM Tris-HC l, pH 8, 10 mM DTT, and 15% glycerol). C ell extracts were prepared by repeated cycles of freezing and thawing. ␤-Galactosidase activity was assayed as described by Sambrook et al. (1989) . CAT activity was determined by thin-layer chromatography and measured as the percentage of conversion of monoacetylated and diacetylated chloramphenicol relative to unmodified plus acetylated chloramphenicol using the Bio-Rad (Hercules, CA) GS-525 Molecular Imager system. CAT activity was standardized to ␤-galactosidase levels to compensate for variations in transfection efficiency. E xperiments were performed in duplicate and repeated a minimum of three times. Error bars in the figures represent SEMs of all replications.
Stable transfectant cell line. A PCR-amplified EcoRI fragment encompassing the f ull-length (845 bp) coding region of zebrafish dl x2 cDNA (described above) was subcloned into the pTL -MTG vector (Prefontaine et al., 1998) downstream of and in frame with six repeats of a c-myc sequence that encodes a polypeptide consisting of an epitope recognized by the 9E-10 monoclonal antibody (myc-tag; Santa Cruz Biotechnology, Santa Cruz, CA). E xpression of this f usion protein is under control of the SV40 early promoter. This construct (pTL -MTG-Dlx2) was cotransfected together with pC M Vneo into SF7 SCID fibroblastic cells, as described above, using the calcium phosphate procedure with the following modifications: 8 g of pTL -MTG-Dlx2 and 2 g of pC M Vneo made up the total DNA transfected per 100 mm dish; 40 hr after transfection 600 g /ml G418 was added to the cells. C ells were maintained in this concentration of G418 until the formation of discernible colonies. Individual colonies of cells were isolated and grown separately. Each clone was screened by PCR for the presence of a zebrafish dl x2 sequence. MTG-Dlx2 protein was prepared from nuclear extracts of the stable transfectant cell line SF7-MTG-Dlx2 essentially as described by Andrews and Faller (1991) . In brief, cells from each confluent 100 mm dish were harvested and resuspended in 1.5 ml PBS on ice. The cell suspension was pelleted and resuspended in 400 l of a cold solution of (in mM): 10 H EPES -KOH, pH 7.9, 1.5 MgC l 2 , 10 KC l, 0.5 DTT, and 0.2 PMSF, incubated on ice 10 min, then vortexed 10 sec. Insoluble nuclei were pelleted and the supernatant, containing cytoplasmic contents and outer membrane, was discarded. Nuclei were resuspended in 20 -100 l of a cold solution of (in mM): 20 H EPES -KOH, pH 7.9, 1.5 MgC l 2 , 420 NaC l, 0.2 EDTA, 0.5 DTT, and 0.2 PMSF and 25% glycerol, and incubated on ice for 20 min. C ellular debris was removed by centrif ugation. Protein concentration of the supernatant was determined by the Bio-Rad protein assay, and single use aliquots were stored at Ϫ80°C.
The presence of MTG-Dlx2 was determined by immunoblotting with the 9E-10 monoclonal antibody. Four individual clones were positive for MTG-Dlx2 after both rounds of screening, and one was chosen for subsequent experiments. It was thereafter maintained in 400 g /ml G418.
Electrophoretic mobilit y shif t assays. DNA fragments corresponding to positions 1-204, 187-316, and, 305-473 of zI46I (Fig. 2 A) , as well as the ⌬210, ⌬266, and ⌬210/⌬266 mutagenized versions of the 187-316 fragment were amplified by PCR. The PCR product was inserted into the pCRII vector (Invitrogen, San Diego, CA). The fragment was excised with EcoRI before filling of the 5Ј overhangs with the large fragment of DNA polymerase I (K lenow) in presence of radiolabeled [␣ 32 P]dATP. Binding reactions were performed in a total volume of 20 l in (in mM): 12 H EPES -KOH, pH 7.9, 1 EDTA, 0.4 MgC l 2 , 100 NaC l, 0.6 DTT, and 0.6 PMSF, and 13% glycerol. Nuclear extract (10 g) from the stable SF7-MTG-Dlx2 cell line or from control SF7 cells was pre-incubated with the 9E-10 anti-myc monoclonal antibody or an equivalent volume of water at room temperature for 30 min. After pre-incubation, 1 g of bovine serum albumin, 1 g of sheared calf-thymus DNA (Boehringer Mannheim), and 15,000 cpm of radiolabeled probe were added and incubated at room temperature for 20 min. Protein -DNA complexes were resolved on a 4% polyacrylamide (29:1 acrylamide:bis-acrylamide) gel run in 1ϫ Tris-borate-EDTA.
RESULTS

Identification of highly conserved elements in the zebrafish dlx4/dlx6 and mouse Dlx5/Dlx6 intergenic regions
We identified two highly conserved sequences in the region between the zebrafish dlx4 and dlx6 genes and their mouse orthologs Dlx5/Dlx6. A 1.4 kb XhoI-EcoRI fragment from the zebrafish dlx4/dlx6 intergenic region ( Fig. 1 ) was found to hybridize to a pair of restriction fragments in the mouse Dlx5/Dlx6 intergenic region. Nucleotide sequence analysis revealed two sequences, of ϳ400 and 300 bp, respectively, that are highly similar between the two species ( Fig. 2 A,B) . The orientation and the relative position of the two sequences relative to dlx4 (Dlx5) and dlx6 (Dlx6 ) are identical ( Fig. 1) . The 400 bp sequence, named zI46i, is closer to the dlx6 gene than is the 300 bp sequence, hereafter named zI46ii. The orthologous mammalian elements are hereafter called mI56i and mI56ii, respectively. We have identified highly similar sequences at the human DLX5/ DLX6 locus by searching the GenBank database ( Fig. 2 A,B) .
Nucleotide sequence comparisons indicate the human and mouse mI56i elements to be identical except for a 3 bp insertion in the human sequence (Fig. 2 A) . The zI46i sequence is 83% identical to its mammalian counterparts over 384 bp (Fig. 2 A) , including a central 131 bp with 94% sequence identity. The human and mouse mI56ii sequences are 98% identical, and zI46ii shares ϳ85% identity over 275 bp with its mammalian counterparts (Fig. 2 B) . The zI46ii sequence lacks a stretch of adenines, ϳ20 nucleotides in length, that is found in the two mammalian sequences. Figure 2 . Conserved sequences in the intergenic region that separates a pair of vertebrate Dlx genes. A, Alignment of I56i sequences from human ( h) and mouse ( m) and zI46i from zebrafish (zf ). B, Alignment of I56ii sequences from human and mouse and zI46ii from zebrafish. The human sequences were retrieved from GenBank, accession number AC004774. Complete sequence identity across the three species is indicated by an asterisk. The nucleotide positions of the intergenic sequences corresponding to putative homeodomain protein recognition sites as characterized by a TAAT/ATTA core sequence are shaded. The two putative Dlx binding sites that were mutagenized are shown in bold. Numbering is relative to the XhoI site (assigned the numerical position of 1) flanking a 1.4 kb element nearest to dlx6 in zebrafish and that contains both I4/6 elements ( Fig. 1) .
A zebrafish dlx4/dlx6 intergenic fragment targets reporter gene expression to the forebrain and olfactory placodes in transgenic mice
A construct containing the lacZ reporter gene under the control of a ␤-globin minimal promoter and the entire zebrafish dlx4/dlx6 intergenic region (plus a short segment of the transcription unit of dlx4 and a few base pairs of the transcription unit of dlx6; zfdlx4/6lacZ transgene; Fig. 1 ) was injected into fertilized mouse eggs to produce transgenic animals. We obtained seven lines of transgenic mice. All seven lines showed lacZ expression, beginning at approximately embryonic day 10 (E10), in two groups of forebrain cells, one in the ventral thalamus/hypothalamus and one in the basal telencephalon ( Fig. 3A ; I and II, respectively). Examination of whole-mount embryos stained for ␤-galactosidase Figure 3 . A DNA fragment encompassing the zebrafish dl x4/dl x6 intergenic region directs expression of lacZ in transgenic mouse embryos with patterns that closely recapitulate endogenous Dl x5 and Dl x6 expression in the forebrain. A-C, lacZ expression in the ventral thalamus (VT ), basal telencephalon (BT ), and olfactory placodes (OP) in E10 ( A), E11 ( B), and E12 ( C) whole-mount mouse embryos. D, Coronal section of an E14.5 stage mouse embryo with lacZ expression in the lateral ganglionic eminence (LGE). Higher ␤-galactosidase activity is seen in the subventricular zone (SV Z) compared to the mantle (MZ). E, F, In situ hybridizations with Dl x5 ( E) and Dl x6 ( F) probes on coronal sections adjacent to that seen in D. Note that the relative patterns of Dlx5 expression in the SVZ and MZ more closely resemble that seen in transgenic animals ( D) than do the relative patterns of Dlx6 expression. G-I, More caudal sections of the same embryonic brain. G, E xpression of ␤-galactosidase in the caudal ganglionic eminence (CGE), preoptic area (POA), and ventral diencephalon. H, I, In situ hybridizations with Dl x5 and Dl x6 probes, respectively, on sections adjacent to those seen in G. Embryos in A and B are from line 7679, and those in C-I are from line 1469. J-L, A 1.4 kb XhoI/EcoRI fragment from the zebrafish dl x4/dlx6 intergenic region directs expression of a transgene that recapitulates endogenous dl x expression in the forebrain of zebrafish embryos. J, E xpression of GFP directed by the 1.4 kb I4/6 zebrafish fragment in a 36 hr embryo. The patterns are similar to the expression of the endogenous dl x4 ( K) and dl x6 ( L) genes. The domains I and II of dlx expression correspond, by analogy, to the diencephalic ( I ) and telencephalic (II) domains of Dl x expression in the mouse. I, Domain I; II, domain II; AEP, anterior entopeduncular area; BT, basal telencephalon; Cx, cortex; Hy, hypothalamus; LV, lateral ventricle; OB, prospective olfactory bulb; Se, septum; SPV, supraoptic paraventricular area; VZ, ventricular zone. activity indicated that the patterns of reporter transgene expression are strikingly similar to patterns of endogenous mouse Dlx expression in the forebrain (Shimamura et al., 1997) . Mouse embryos express Dl x5 and Dl x6 in two separate domains within the forebrain. Domain I is a longitudinal alar plate stripe that begins at the zona limitans intrathalamica and extends rostrally through the ventral thalamus (V T) and several hypothalamic areas (Hy) to the rostral midline. Domain II is a longitudinal region in the basal telencephalon that extends rostrally from part of the caudal ganglionic eminence (CGE; amygdala primordium), through the lateral ganglionic eminence (LGE) and medial ganglionic eminence (MGE), and into the septal and preoptic (POA) primordia (Bulfone et al., 1993b ; L. Puelles, E. Kuwana, A. Bulfone, K . Shimamura, J. Keleher, S. Smiga, E. Puelles, and J. Rubenstein, unpublished observations).
Similarly to endogenous Dl x5 and Dl x6, expression of the reporter transgene decreased after E14.5, and lacZ transcripts were virtually undetectable at postnatal day 0 (P0). Yet, ␤-galactosidase activity persisted much longer and, in some areas, remained strong even in the adult (P120) brain (data not shown). A higher sensitivity of the enzymatic assay for ␤-galactosidase activity compared to in situ hybridization or the sheltering of the ␤-galactosidase protein from metabolism could explain the apparent persistence of ␤-galactosidase compared to the lacZ transcripts. In addition to the developing forebrain, the reporter transgene under the control of zebrafish sequences was expressed in the olfactory placodes in five of seven mouse lines (Figs. 1,  3A ,B). There were very few additional sites of transgene expression: one line had a few labeled eye cells; one line had expression in the developing shoulder area, and one showed expression in the trunk somites (data not shown). Additional sites of endogenous mouse Dl x5 and Dl x6 expression were negative, including the branchial arches, the otic vesicle, and the limb apical ectodermal ridge (AER).
To assess the degree to which expression of the zfdlx4/6lacZ transgene matches endogenous Dl x5 and Dl x6 expression in the forebrain, we have compared their expression patterns, using X-gal staining and radioactive in situ hybridization, respectively, on transverse brain sections. We analyzed sequential sections from E10.5, E12.5, E14.5, E17.5, and P0 mice.
Dlx5 and 6 are expressed in domains I and II in slightly different, but overlapping patterns: Dl x5 is expressed strongest in the subventricular zone (SVZ), whereas Dl x6 is expressed strongest in the mantle zone (MZ) (Fig. 3E,F ) . Neither gene is expressed appreciably in the ventricular zone (VZ) (Liu et al., 1997) .
Remarkably, the zfdl x4/6lacZ transgene is expressed in a pattern extremely similar to that of the mouse Dl x5 and Dlx6 genes. It is apparent, however, that despite the degree of overlap between the zfdl x4/6lacZ transgene and Dl x5 and Dl x6 genes, there is a greater similarity between the zfdl x4/6-enhancer-driven lacZ and Dl x5 expression patterns. ␤-Galactosidase activity and Dlx5 transcripts can first be detected in the forebrain at ϳE10, as a thin layer of cells overlying parts of the ventricular zones in the basal telencephalon and diencephalon, respectively. On E10.5, E12.5, and E14.5, zebrafish dl x4/6-enhancer driven ␤-galactosidase expression in the mouse telencephalon matches mouse Dl x5 expression more closely than that of Dl x6 ( Fig. 3D -I ; data not shown). In domain I, the zfdl x4/6lacZ transgene has a pattern that also appears to be more similar to that of Dl x5 than Dl x6 (Fig. 3G-I ).
The zebrafish dlx4/dlx6 intergenic enhancer is active in the forebrain of zebrafish embryos
To determine if the intergenic sequences that target reporter gene expression to the forebrain of transgenic mice can reproduce dlx expression in zebrafish embryos, we microinjected, into one-cell stage embryos, a construct that contained the 1.4 kb zebrafish EcoRI-XhoI intergenic fragment from dlx4/dlx6 (Fig. 1) , the same ␤-globin minimal promoter fragment as for the transgenic mouse experiments, and the gene coding for the GFP as a reporter. Primary transgenic zebrafish embryos carrying this construct expressed GFP specifically in forebrain cells forming two domains (Fig. 3J ) with patterns strikingly similar to endogenous dlx4/dlx6 expression (Fig. 3K,L) . Of the 750 embryos that survived microinjection until the second day of embryonic development, four had very high levels of GFP expression in the forebrain, 25 had 5-10 GFP-positive forebrain cells, and 30 had one or two positive forebrain cells. Fifteen embryos showed one or a few GFP-positive cells in ectopic locations. The onset of GFP expression in the forebrain was ϳ17-19 hr after fertilization (hpf), shortly after the onset of dlx4 expression as detected by in situ hybridization. GFP expression persisted in the forebrain until at least 36 hpf.
The two domains of dlx expression in the forebrain of zebrafish embryos (Akimenko et al., 1994) are reminiscent of the two domains observed in the mouse embryonic forebrain. To compare expression patterns of dlx genes in the zebrafish forebrain, we made sections of 48-hr-old embryos hybridized with dlx probes. Interestingly, the patterns of expression of dlx1 and dlx2 in both the telencephalon and the diencephalon indicate that the two genes are expressed in more immature cells, as reflected by their position closer to the ventricular walls than the cells that express dlx4 and dlx6 (Fig. 4) . A similar observation had been made previously for the mouse orthologs of these four genes (Liu et al., 1997) .
Most of the forebrain activity of the dlx4/dlx6 intergenic enhancer is located in zI46i
The two conserved sequences located in the zebrafish dlx4/dlx6 intergenic region (zI46i and zI46ii) were inserted separately into reporter constructs and used to produce transgenic mouse embryos. At E11, forebrain lacZ expression targeted by the zI46i enhancer construct was indistinguishable from that targeted by the full-length I4/6 enhancer (compare Figs. 5A, 3B), although none of the embryos showed expression in the olfactory epithelium (n ϭ 12; Fig. 1 ).
We also generated transgenic mice with a reporter construct that contained the second conserved sequence from the zebrafish dlx4/dlx6 intergenic region zI46ii. Two lines of transgenic mice and 10 primary transgenic mouse embryos were produced. Embryos from one transgenic line showed lacZ expression in the olfactory epithelium (data not shown) resembling that obtained with the full-length I4/6. This was also observed in one primary transgenic embryo, which, in addition, had expression in the AER of the limb buds, where Dlx genes are expressed (Dollé et al., 1992; Bulfone et al., 1993a) . Finally, one primary zI46ii transgenic embryo showed correct lacZ expression in the forebrain (data not shown). Thus, zI46ii was much less efficient at targeting lacZ to the forebrain (0 of 2 lines; 1 of 10 primary transgenic embryos) compared to full-length I4/6 (seven of seven lines) or to zI46i (12 of 12 primary transgenic embryos; Fig. 1 ).
We next tested whether the orthologous mouse mI56i could regulate correct Dlx expression in the forebrain. Four stable lines and four primary transgenic embryos were produced with the mI56i construct, and nearly all showed forebrain expression (Fig.  5B) ; one transgenic line did not express lacZ any where, possibly because of an integration effect. Reversing the orientation of mI56i had no effect on its expression (nine of nine primary transgenic embryos; Fig. 1 ; data not shown). Thus, both the orthologous mI56i and the zI46i fragments are enhancers that efficiently replicate the correct pattern of Dl x expression in the forebrain.
Unlike the zI46i enhancer, mI56i in either orientation frequently reproduced correct Dl x expression in the branchial arches (two of four stable lines and seven of 13 primary embryos; sum of both orientations, Figs. 1, 5B ; data not shown), olfactory placode (one line and one primary embryo) and AER (one line; Fig. 1 ). No expression in the otic vesicle was observed in any embryos, but some expression was detected in the middle ear, which is consistent with the branchial arch expression.
To begin to identif y the essential sequences within these enhancers, we used a deletion fragment of the zI46i enhancer, corresponding to positions 187-316 (Fig. 2 A) and examined its activity in transgenic mouse embryos at E11. Of five primary transgenic embryos, all appeared to have correct expression in domain II in the forebrain (Fig. 5C ). However, ␤-galactosidase expression in domain I (ventral thalamus and hypothalamus) was occasionally weaker or not detectable (data not shown). A similar construct also targeted expression of GFP principally to the forebrain of zebrafish embryos (data not shown).
Activity of the zebrafish intergenic enhancer is reduced in mice lacking Dlx1 and Dlx2
Mutant mice that lack both Dlx1 and Dlx2 function have a time-dependent block in basal telencephalon differentiation (Anderson et al., 1997b) . Although early neurogenesis appears to be normal, later neurogenesis is not. This phenotype seems to be caused by a defect in the production and/or function of the subventricular zone. Accordingly, in Dlx1/2 mutants Dlx5 and Dlx6 expression is not detectable in the subventricular zone of the LGE and MGE, but is maintained in early born mantle cells at E12.5 (Anderson et al., 1997b ). As described above, the zebrafish and mouse intergenic enhancers are highly active in the SVZ of the basal telencephalon. Therefore, it is possible that the Dlx1 or Dlx2 proteins might be, at least in part, responsible for the activity of this enhancer. To test this hypothesis, we bred mice containing the zebrafish dlx4/dlx6 full intergenic reporter con- Figure 4 . The dl x1 and dlx2 genes are expressed in more immature cells of the zebrafish forebrain than their dlx4 and dlx6 paralogs. Transverse sections of 48-hr-old zebrafish embryos at the level of the telencephalon (A, C, E, G) and of the diencephalon (B, D, F, H ) are shown with dorsal at the top. C ells that express dl x1 and dlx2 are closer to the ventricle compared to those expressing dl x4 or dl x6. The expression of dl x2 closer to the ventricle compared to dl x4 confirms our previous observation (Akimenko et al., 1994) . struct with mice heterozygous for a mutation that inactivates both Dlx1 and Dl x2. We then inbred mice that are heterozygous for both the mutation and the transgene to generate Dlx1/2Ϫ/Ϫ homozygotes that also had at least one zfdl x4/dl x6lacZ allele.
In embryos that are homozygous for the Dl x1/Dl x2 mutation, ␤-galactosidase activity is strikingly reduced in the subventricular zone of the developing striatum (Fig. 6 A-D) . These results parallel the changes in endogenous Dl x5 and Dl x6 expression in the Dlx1/2 mutant mice (Fig. 6 E-L) . Based on these results, we propose that Dl x1 and /or Dl x2 f unction is required, directly or indirectly, to regulate Dl x5 and Dl x6 expression via their intergenic enhancer.
To determine whether the loss of Dl x5, Dl x6, and zfdlx4/6lacZ expression in the SVZ of the Dl x1/2 mutants is attributable to a loss of those cells or to a change in gene regulation in SVZ cells, we studied the expression of Dl x1 and Dl x2 mRNAs. In the Dlx1/2 mutants, the 5Ј end of these genes was not deleted (Qiu et al., 1997) . Thus, if the Dl x1/2 cis-acting regulatory sequences responsible for Dl x1/2 expression are intact, and the truncated Dlx1 and /or Dl x2 transcripts are stable, we should be able to detect the cells that normally express Dl x1/2 in these mutants. In fact, in situ hybridization demonstrates that both truncated genes are still expressed in the proliferative zones of the Dl x1/2 mutants (Fig. 6 M-P; data not shown). This strongly supports the model that cells expressing Dl x1/2 are maintained in the mutants and that there is molecular dysregulation within these cells leading to the loss of Dl x5, Dl x6, and zfdl x4/6lacZ expression.
Dlx proteins can upregulate transcription from conserved intergenic sequences
Dlx proteins bind DNA and can regulate transcription (Liu et al., 1997; Z hang et al., 1997) . Because analysis of Dl x1/2 mutant mice suggests that Dlx1 and /or Dlx2 f unction is necessary for proper expression of Dl x5/Dl x6, one possibility is that this interaction is directly mediated by transcriptional activation of the intergenic enhancer(s) by Dlx1 or Dlx2. To test this model, we performed transient cotransfection assays in cultured cells. Reporter plasmids were constructed to contain either the zebrafish 1.4 kb I4/6 fragment, which contains both zI46i and zI46ii, or to contain only one of these elements. Effector plasmids were constructed to express full-length zebrafish Dlx1, Dlx2, Dlx3, Dlx4, or Dlx6 proteins under the control of the SV40 early promoter, or fulllength mouse Dlx1, Dlx2, or Dlx5 proteins under the control of the cytomegalovirus promoter.
Cotransfection, into mouse P19 murine embryonic carcinoma cells, of a construct expressing the zebrafish Dlx2 protein resulted in a 20-fold increase in the activity of the CAT reporter gene placed under the control of the 1.4 kb dlx4/dlx6 intergenic fragment (Fig. 7A) . All of the zebrafish Dlx expression vectors were able to activate expression of the reporter construct to a similar extent (data not shown). The mouse Dlx1, Dlx2, and Dlx5 expression vectors were also able to activate transcription of the same reporter construct in a neuroepithelial cell line (MNS-71; G. Yu, T. Zerucha, M. Ekker, and J. L. R. Rubenstein, unpublished observations). This indicates that Dlx proteins from either zebrafish or mouse are able to recognize similarly the zebrafish intergenic enhancer sequences in at least two different cell types. Not all homeodomain proteins could activate transcription from the 1.4 kb dlx4/dlx6 intergenic fragment; the products of several sine oculis-related genes (six genes) were unable to activate transcription from this sequence (data not shown).
To determine if both zI46i and zI46ii contain targets for Dlx proteins, the same Dlx expression constructs were cotransfected with reporter constructs containing either zI46i or zI46ii. All Dlx proteins examined activated expression through the zI46i element ( Fig. 7A ; data not shown) but none activated transcription from a reporter containing zI46ii ( Fig. 7A ; data not shown), except perhaps for a weak (less than twofold activation) by the mouse Dlx5 protein. Furthermore, the degrees of activation produced by Dlx proteins on zI46i reporter constructs were comparable to those obtained with the 1.4 kb I4/6 fragment.
In an attempt to narrow down the region of zI46i required for activation by Dlx proteins, a series of deletion fragments of zI46i were prepared and subcloned into the reporter plasmid. The orientation of each of the deletion fragments was maintained relative to the orientation of the f ull-length zI46i. In transient cotransfection experiments, Dlx2 activated transcription of constructs containing the 187-316 deletion fragment to an extent similar to that observed with the f ull-length zI46i (Fig. 7A) . However, Dlx2 did not activate transcription of constructs containing either the 1-204 or 305-473 fragments (Fig. 7A) .
Recently a consensus DNA-binding site was identified for the Xenopus Dlx3 ortholog, Xdll2 using a binding site selection procedure from a random oligonucleotide pool (Feledy et al., 1999) . The consensus site identified is (A /C /G)TAATT(G/A)(C/G). Because of the similarity of the homeodomains of the Dlx family, it is likely that Dlx proteins other than those of the Dlx3 paralogous group will recognize a similar sequence. The 187-316 fragment of zI46i that is activated by Dlx2 contains two sites consistent with this consensus sequence. These two sites correspond to positions 207-214 and 263-270 of the zI46i sequence (Fig. 2) . We mutagenized these two sites, individually or in combination. Mutagenesis of either site or of both sites almost entirely abolishes the activation of transcription by Dlx2 (Fig. 7B) . When tested in transgenic mice, a construct that contained mutations in both putative binding sites had little if any activity in the forebrain. Of seven primary transgenic mouse embryos, three had no detectable lacZ expression in the forebrain, and two had a few weakly positive cells at the anterior end of domain II (data not shown). These positive cells represented only a very small fraction of the endogenous pattern. Combined with our observation that activity of the forebrain enhancer is dramatically decreased in mice lacking Dlx1 and Dx2 function (Fig. 6) , these results indicate that activation by Dlx proteins, presumably by Dlx1 and/or Dlx2, is essential for the activity of the I46 enhancer in the forebrain.
To determine if the Dlx proteins are able to directly interact with the zI46i element, electrophoretic mobility shift assays were performed. Nuclear extracts from SF7 SCID fibroblasts expressing a fusion of a c-myc fragment with full-length zebrafish Dlx2 (MTG-Dlx2) produced a lower mobility complex with the 187- Figure 6 . Forebrain expression of a reporter gene driven by I4/6 is drastically reduced in mice with a targeted null mutation of the Dl x1 and Dlx2 genes. A, B, Coronal sections through the telencephalon of wild-type ( A) and Dl x1/Dl x2 mutant ( B) E12.5 embryos that both contain the zfdl x4/6lacZ transgene. C, D, Coronal sections through the telencephalon of wild-type ( C) and mutant ( D) E14.5 embryos. LacZ expression is virtually absent from the lateral (LGE) and medial (MGE) ganglionic eminences of the mutants, but is preserved in the rostral mantle (B, asterisk). E-P, In situ hybridization on sections adjacent to the ones shown in A-D with probes for Dl x5 ( E-H), Dl x6 ( I-L), and Dl x1 ( M-P). The Dl x1 probe recognizes a sequence in the 5Ј end of the Dlx1 mRNA that is retained in the mutant (see Results). The asterisk in D, H, and L denotes an area in the septal /preoptic region of Dlx1/Dlx2 mutants where Dlx5 and Dl x6 expression at late embryonic stages appears not to be matched by lacZ expression. Other abbreviations as in Figure 3 . 316 deletion fragment of zI46i (Fig. 8 A) . Migration of the lower mobility complex obtained with MTG-Dlx2 was f urther retarded in the presence of the 9E-10 anti-c-myc antibody, indicating the lower mobility complex contains MTG-Dlx2. No complexes of lower mobility were obtained with a control SF7 nuclear extract (Fig. 8 A) . Furthermore, neither of the other two deletion fragments of zI46i (1-204 and 305-473 ) produced a complex of lower mobility in the presence of MTG-Dlx2-containing SF7 extract (Fig. 8 A) , a result consistent with the absence of activation, by Dlx2, of reporter constructs containing these intergenic fragments in cotransfection experiments.
We next examined the effects of mutagenesis of the putative binding sites. As seen in Figure 8 B, the ⌬210 and ⌬266 mutagenized fragments both produced a shift of lower mobility that migrated to the same place as that obtained with the wild-type 187-316 fragment. These shifts could be supershifted with the 9E-10 antibody. In contrast, we observed no supershift when the double mutant fragment was incubated with the MTG-Dlx2 and 9E-10 (Fig. 8 B) . Mutation at the 210 site seems to increase background binding, which is also observed in the control Sf7 extract and overlaps with the expected position for the Dlx2-DNA complex. This is especially evident for the double mutant but can also be seen in the ⌬210 lanes.
The similar migrations of the lower mobility complexes obtained with the wild-type and single mutant fragments suggest that we can only observe the wild-type fragment bound by one Dlx2 molecule. This is consistent with the observation that only a small proportion of the labeled fragment is bound and suggests that Dlx2 binds to the two sites independently instead of cooperatively, which is not surprising considering the relatively large distance that separates the two binding sites (ϳ56 bp). The fragment bound by two Dlx2 molecules would be proportionally too weak to be observed in this assay.
Taken together with the results of our transient expression assays (Fig. 7) , our observations suggest that two Dlx2 protein molecules bind to the zI46i enhancer independently but that optimal function of the enhancer requires occupancy of the two binding sites.
DISCUSSION
One intergenic enhancer is sufficient to recapitulate forebrain Dlx expression
A zebrafish sequence from the intergenic region between the dlx4 and dlx6 genes is sufficient, once combined to a minimal promoter, to direct expression in cells of the telencephalon and diencephalon, of either zebrafish or mice, that normally express Dlx genes (Fig. 3) . This strongly suggests that the regulatory mechanisms controlling Dlx expression in the forebrain have been conserved during vertebrate evolution, and it lends support to the idea that Dlx function during forebrain development has also been conserved. Additional evidence for conserved function of Dlx genes in forebrain development comes from the differential expression of Dlx genes in the telencephalon and diencephalon where more immature cells express Dlx1 and Dlx2 compared to Dlx5 and Dlx6, as seen both for the mouse genes (Liu et al., 1997) and for their zebrafish orthologs ( Fig. 4 ; Akimenko et al., 1994) .
Functional conservation of enhancer sequences between mammals and teleost fish has been previously observed for the Otx2 (Kimura et al., 1997) , hoxb1 (Marshall et al., 1994) , and the Hoxd-11 genes (Beckers et al., 1996; Gerard et al., 1997) , although in the latter case, temporal, spatial, and mechanistic differences could be observed between the fish enhancer and its mammalian counterpart.
Comparisons of the enhancer activities of zI46i (mI56i) and zI46ii suggest the former plays a more important role in forebrain expression. zI46ii may still be necessary for optimal Dlx expression in the ventral forebrain, but this enhancer may require, to function efficiently, the presence of other regulatory sites, either from zI46i or from the promoters of one or both flanking genes.
Detailed analysis of reporter transgene activity in the mouse forebrain suggests that both the full dlx4/dlx6 intergenic construct and the zI46i (mI56i) sequences reproduce the endogenous Dlx5 expression pattern more faithfully than the Dlx6 expression pattern. This was observed principally by comparison of ␤-galactosidase expression and endogenous transcript levels in the LGE and MGE of the telencephalon (Fig. 3) . Identical results were obtained with constructs from either zebrafish or mouse origin. Therefore, the observed differences cannot be attributed solely to the inability of a zebrafish enhancer to precisely recapitulate Dlx expression in a mouse embryo. One possible explanation for this result is that sequences, necessary for maximal expression in cells of the mantle, are absent from our constructs, and, therefore, located outside the intergenic region. It is also possible that, although the intergenic enhancer is sufficient to direct expression to the ventral forebrain, its activity is modulated by specific interactions with other cis-acting regulatory elements, such as the promoters of each of the two flanking genes, Dlx5 and Dlx6. An overall distinct set of transcriptional activators binding to upstream and intergenic regulatory sequences would be responsible for the differences in Dl x5 and Dl x6 expression patterns. Experiments in zebrafish designed to examine the interactions between the intergenic forebrain enhancer and the dl x4 and dlx6 promoters are presently under way to address this issue. In summary, although it is possible that the intergenic forebrain enhancer is shared between Dl x5 and Dl x6, which would explain their partially overlapping patterns of expression, additional mechanisms must account for the overall distinct expression of the two genes in the forebrain.
Transgenic animals carrying constructs containing both zI46i and zI46ii always exhibit expression of the reporter gene in the ventral forebrain. Reporter expression is often seen in the olfactory placodes, but never in regions of the embryo, such as the branchial arches, the inner ear, and the AER of the limb buds where Dl x5 and Dl x6 or their zebrafish orthologs are also expressed. These results suggest that elements necessary for proper expression in the latter areas are located outside the conserved Dlx5/Dlx6 intergenic region. On the other hand, several transgenic animals with the zI46i or mI56i constructs showed expression in the ectomesenchyme of the branchial arches reminiscent of endogenous Dlx expression. The mechanisms that underlie such results are, at present, unclear but may involve integration effects. It is also possible that intergenic sequences, outside zI46i (mI56i) are necessary to restrict the activity of this enhancer to the ventral forebrain.
Dlx proteins interact with the forebrain-specific regulatory sequences
Expression of Dlx5 and Dlx6 is affected in the ventral forebrain of Dlx1/2 null mutants (Anderson et al., 1997b) . Thus, Dlx5 and Dlx6 transcripts are not detectable in the SVZ of the LGE at E12.5 and E14.5. Like endogenous Dlx5 and Dlx6, the activity of the zebrafish dlx4/dlx6 intergenic transgene (I4/6) is drastically reduced in the Dlx1/2 null mutants (Fig. 6) . The mostly normal expression of the truncated Dlx1 and Dlx2 transcripts in forebrain cells of the mutant (Fig. 6 ; data not shown) suggests that the SVZ cells that normally express Dlx5 and Dlx6 are still present. There- Figure 8 . A, The zebrafish Dlx2 protein binds the 187-316 fragment of zI46i in a gel mobility shift assay. Three fragments from zI46i: 1-204, 187-316, and 305-473 were radiolabeled and incubated with a nuclear extract from an SF7-derived cell line that expresses MTG-Dlx2 or with a control SF7 nuclear extract. A lower mobility complex is indicated by the solid arrow. In the presence of the 9E-10 antibody directed against the MTG epitope of MTG-Dlx2, this mobility complex is supershifted (open arrow). B, Mutagenesis of the two putative binding sites in the zI46i 187-316 fragment impairs binding by the Dlx2 protein.
Only those lower mobility complexes obtained after incubation of MTGDlx2 with the wild-type 187-316 or with fragments containing one mutagenized site (⌬210 or ⌬266) can be supershifted by the 9E-10 antibody. A smear around the same mobility as this retarded complex can be obtained with the fragment containing the two mutations (⌬210/266), but is also seen with the control SF7 extract and is not supershifted by the 9E-10 antibody.
fore, the reductions in Dl x5 and Dl x6 expression and in transgene activity strongly suggest that Dl x1 and /or Dl x2 are required for the induction and /or maintenance of Dl x5 and Dl x6 expression and that this is mediated by the intergenic enhancer sequences. This might be achieved by direct regulation of Dl x5/Dl x6 expression by the Dlx1 or Dlx2 proteins which can f unction as transcriptional activators (Liu et al., 1997; Z hang et al., 1997) . Such cross-regulatory interactions involving homeobox genes have been described, for example, for members of the Hox clusters Nonchev et al., 1997; Studer et al., 1998) and for the zebrafish dl x genes (Z erucha et al., 1997). Alternatively, Dlx1 or Dlx2 may activate a yet unknown factor that is an essential regulator of Dl x5 and Dl x6 expression. The above two mechanisms are not mutually exclusive. Our finding that the Dlx2 (Fig. 7A ) and Dlx1 (data not shown) proteins, of either zebrafish or mouse origin are able to upregulate transcription of reporter constructs containing the conserved I4/6 intergenic sequences in cotransfection experiments supports the view that these sequences are the site of cross-regulatory interactions in vivo. Upregulation by Dlx2 was almost completely abolished when the putative binding sites were mutagenized (Fig. 7B ). Furthermore, we were able to demonstrate binding of Dlx2 to the 187-316 fragment of zI46i in gel mobility shift assays (Fig. 8 A) . Mutagenesis of both sites in 187-316 abolished binding by the Dlx2 protein (Fig. 8 B) . The 187-316 fragment of zI46i is responsible for most if not all of the activation by Dlx proteins in transfection experiments and is able to target transgene expression to the ventral forebrain in mice and zebrafish.
The loss of Dl x1 and Dl x2 expression only eliminates Dlx5, Dlx6, and zfdl x4/6lacZ transgene expression in the SVZ, whereas their expression is maintained in the early-born mantle cells of the rostral telencephalon (Fig. 6 ). This observation indicates that other transcription factors regulate Dl x5, Dl x6, and I4/6lacZ expression in a subset of early forebrain cells. Furthermore, the loss of Dlx5 and Dl x6 expression in the SVZ of the Dl x1/Dlx2 null mutants also raises the possibility that the mutant phenotype may be attributable to the loss of f unction of all four genes, implying some f unctional redundancy between them. This is also supported by the recent observation that loss of Dl x5 f unction alone does not produce any obvious forebrain phenotype (Acampora et al., 1999; Depew et al., 1999) . A better understanding of any differences in biochemical activities of Dlx proteins, such as involvement in specific protein -protein interactions, would help elucidate the f unctional consequences of the partially overlapping expression of these genes during development.
Intergenic region and Dlx gene evolution
The high degree of sequence similarity that we observed in the intergenic region between a pair of Dl x genes of mouse, human, and teleost fish (Fig. 2) is remarkable, considering that these sequences are outside the coding regions of either genes. High degrees of sequence similarity outside gene coding regions have been observed previously between human and mouse sequences (for example, see Becker et al., 1996; Williams et al., 1998) , and some sequence conservation has also been found with sequences of distantly related vertebrates such as the pufferfish, Fugu rubripes, and zebrafish (Marshall et al., 1994; Morrison et al., 1995; Beckers et al., 1996; K imura et al., 1997) . However, none of the above examples compare in length and /or in percentage identity with the elements we report in the present study.
The convergently transcribed configuration of pairs of distalless-related genes is ancient because it has been reported for the ascidian Ciona intestinalis (Di Gregorio et al., 1995) . The distance that separates the two genes is relatively small (2-10 kb) for all cases reported thus far. It is likely that the paired organization arose after the divergence of arthropods from the lineage that would give rise to vertebrates because insects are thought to have only one distal-less gene. It is possible that one or a few regulatory sequences found downstream of the distal-less gene in the common ancestor to modern day invertebrates and vertebrates were preserved after the first duplication and inversion event that produced the first pair of distal-less/Dlx genes. Enhancer sequences have been described downstream of the Drosophila distal-less gene (Vachon et al., 1992; O'Hara et al., 1993 ) and it will be interesting to determine if there is any degree of functional conservation in these enhancers and those described in the current study. A potential evolutionary advantage of enhancersharing by the two linked genes would be consistent with the conservation of the paired, convergently transcribed configuration and in particular the maintenance of a relatively short intergenic distance. Enhancer sharing has been previously demonstrated for some of the clustered Hox genes (van der Hoeven et al., 1996; Gould et al., 1997; Sharpe et al., 1998) .
Vertebrates have at least three pairs of linked Dlx genes (Simeone et al., 1994; McGuinness et al., 1996; Ellies et al., 1997; Liu et al., 1997) , the Dlx1/Dlx2, Dlx5/Dlx6 (dlx4/dlx6 in zebrafish), and Dlx3/Dlx7 pairs. The presence of conserved regulatory sequences may not be unique to the Dlx5/Dlx6 gene pair because the Dlx1/Dlx2 intergenic region also contains highly conserved sequences (T. Zerucha, M. Qiu, J. K. Liu, J. L. R. Rubenstein, and M. Ekker, unpublished observations), although the roles of such sequences in Dlx gene regulation are, at present, unclear. The function and evolution of intergenic enhancer sequences, combined with studies of the functional specificity of Dlx genes, will enable us to understand the mechanistic basis for the concerted action of Dlx proteins in embryonic cells and the position of the Dlx genes in regulatory cascades during development.
